Pharmacokinetic and Clinical Phase II Trial of Imatinib in Patients with Impaired Liver Function and Advanced Hepatocellular Carcinoma

F. Eckel; S. von Delius; M. Mayr; M. Dobritz; F. Fend; C. Hosius; E. Schleyer; E. Schulte-Frohlinde; R.M. Schmid; C. Lersch

doi:10.1159/000089990

Pharmacokinetic and Clinical Phase II Trial of Imatinib in Patients with Impaired Liver Function and Advanced Hepatocellular Carcinoma

Oncology ◽

10.1159/000089990 ◽

2005 ◽

Vol 69 (5) ◽

pp. 363-371 ◽

Cited By ~ 37

Author(s):

F. Eckel ◽

S. von Delius ◽

M. Mayr ◽

M. Dobritz ◽

F. Fend ◽

...

Keyword(s):

Hepatocellular Carcinoma ◽

Liver Function ◽

Phase Ii ◽

Phase Ii Trial ◽

Advanced Hepatocellular Carcinoma ◽

Impaired Liver Function ◽

Clinical Phase ◽

Impaired Liver

Pharmacokinetic (PK) and clinical phase II trial of imatinib in patients with impaired liver function and advanced hepatocellular carcinoma (HCC)

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.4135 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 4135-4135 ◽

Cited By ~ 1

Author(s):

F. Eckel ◽

S. von Delius ◽

M. Dobritz ◽

F. Fend ◽

C. Hosius ◽

...

Keyword(s):

Hepatocellular Carcinoma ◽

Liver Function ◽

Phase Ii ◽

Phase Ii Trial ◽

Advanced Hepatocellular Carcinoma ◽

Impaired Liver Function ◽

Clinical Phase ◽

Impaired Liver

SO-6 The influence of liver function on the outcomes of phase II trial of sorafenib vs. hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma

Annals of Oncology ◽

10.1016/j.annonc.2020.04.021 ◽

2020 ◽

Vol 31 ◽

pp. S219

Author(s):

S. Kobayashi ◽

M. Kondo ◽

M. Morimoto ◽

H. Hidaka ◽

T. Nakazawa ◽

...

Keyword(s):

Hepatocellular Carcinoma ◽

Liver Function ◽

Phase Ii ◽

Phase Ii Trial ◽

Hepatic Arterial Infusion ◽

Hepatic Arterial Infusion Chemotherapy ◽

Advanced Hepatocellular Carcinoma ◽

Arterial Infusion ◽

Arterial Infusion Chemotherapy ◽

Infusion Chemotherapy

Treating patients with advanced hepatocellular carcinoma and impaired liver function: Broadening the reach of anti‐cancer therapy

Liver Cancer International ◽

10.1002/lci2.37 ◽

2021 ◽

Author(s):

Antonio D'Alessio ◽

Claudia Angela Maria Fulgenzi

Keyword(s):

Hepatocellular Carcinoma ◽

Cancer Therapy ◽

Liver Function ◽

Advanced Hepatocellular Carcinoma ◽

Impaired Liver Function ◽

Impaired Liver ◽

Anti Cancer

Phase II trial of sorafenib in combination with 5-fluorouracil infusion in advanced hepatocellular carcinoma

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-011-1753-2 ◽

2011 ◽

Vol 69 (3) ◽

pp. 773-780 ◽

Cited By ~ 36

Author(s):

Iacopo Petrini ◽

Monica Lencioni ◽

Miriam Ricasoli ◽

Mauro Iannopollo ◽

Cinzia Orlandini ◽

...

Keyword(s):

Hepatocellular Carcinoma ◽

Phase Ii ◽

Phase Ii Trial ◽

Advanced Hepatocellular Carcinoma

Phase II Trial of Hepatic Arterial Infusion Chemotherapy Using Cisplatin and 5-Fluorouracil in Patients with Advanced Hepatocellular Carcinoma

Progress in Hepatocellular Carcinoma Treatment ◽

10.1007/978-4-431-67913-4_7 ◽

2000 ◽

pp. 49-55 ◽

Cited By ~ 2

Author(s):

Masatoshi Tanaka ◽

Eiji Ando ◽

Sigeru Yutani ◽

Kazuta Fukumori ◽

Ryoko Kuromatsu ◽

...

Keyword(s):

Hepatocellular Carcinoma ◽

Phase Ii ◽

Phase Ii Trial ◽

Hepatic Arterial Infusion ◽

Hepatic Arterial Infusion Chemotherapy ◽

Advanced Hepatocellular Carcinoma ◽

Arterial Infusion ◽

Arterial Infusion Chemotherapy ◽

Infusion Chemotherapy

Abstract CT084: HEPANOVA: A phase II trial of tumor treating fields concomitant with sorafenib for advanced hepatocellular carcinoma

10.1158/1538-7445.am2018-ct084 ◽

2018 ◽

Author(s):

Anca-Ligia Grosu ◽

Josif Strouthos ◽

Thomas Brunner ◽

Uri Weinberg

Keyword(s):

Hepatocellular Carcinoma ◽

Phase Ii ◽

Phase Ii Trial ◽

Advanced Hepatocellular Carcinoma ◽

Tumor Treating Fields

983P Camrelizumab (C) in combination with apatinib (A) in patients with advanced hepatocellular carcinoma (RESCUE): An open-label, multi-center, phase II trial

Annals of Oncology ◽

10.1016/j.annonc.2020.08.1099 ◽

2020 ◽

Vol 31 ◽

pp. S689

Author(s):

J. Xu ◽

J. Shen ◽

S. Gu ◽

Y. Zhang ◽

L. Wu ◽

...

Keyword(s):

Hepatocellular Carcinoma ◽

Phase Ii ◽

Phase Ii Trial ◽

Advanced Hepatocellular Carcinoma ◽

Open Label

A phase II trial of thalidomide, α-Interferon +/–octreotide in patients with advanced hepatocellular carcinoma

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.4272 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 4272-4272 ◽

Cited By ~ 2

Author(s):

K. Rasila ◽

F.-C. Lee ◽

I. Rabinowitz

Keyword(s):

Hepatocellular Carcinoma ◽

Phase Ii ◽

Phase Ii Trial ◽

Advanced Hepatocellular Carcinoma

A multicenter, single arm phase II trial of a small molecule immune-modulator icaritin: Safety, overall survival, immune dynamics, and PD-L1 expression in advanced hepatocellular carcinoma.

Journal of Clinical Oncology ◽

10.1200/jco.2018.36.15_suppl.4077 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. 4077-4077 ◽

Cited By ~ 2

Author(s):

Yan Sun ◽

Qing Li ◽

Jian-Ming Xu ◽

Jun Liang ◽

Ying Cheng ◽

...

Keyword(s):

Hepatocellular Carcinoma ◽

Overall Survival ◽

Phase Ii ◽

Small Molecule ◽

Phase Ii Trial ◽

Advanced Hepatocellular Carcinoma ◽

Immune Modulator

Survival Benefits of Small Anatomical Resection of the Liver for Patients with Hepatocellular Carcinoma and Impaired Liver Function, Based on New-Era Imaging Studies

Journal of Cancer ◽

10.7150/jca.15174 ◽

2016 ◽

Vol 7 (9) ◽

pp. 1029-1036 ◽

Cited By ~ 2

Author(s):

Masahiko Sakoda ◽

Shinichi Ueno ◽

Satoshi Iino ◽

Kiyokazu Hiwatashi ◽

Koji Minami ◽

...

Keyword(s):

Hepatocellular Carcinoma ◽

Liver Function ◽

Anatomical Resection ◽

Imaging Studies ◽

Impaired Liver Function ◽

New Era ◽

Resection Of The Liver ◽

Impaired Liver